Critical review of bone health, fracture risk and management of bone fragility in diabetes mellitus

doi:10.4239/wjd.v12.i6.706

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6744)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-3) series.

Item

Count

PDF

449

WORD

210

HTML

3786

Figures (1-5)

442

Tables (1-3)

308

Sum=5195

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

467

Download

1082

Sum=1549

Jun 15, 2021 (publication date) through Nov 29, 2024

Times Cited of This Article

Times Cited (14)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Diabetes. Jun 15, 2021; 12(6): 706-729
Published online Jun 15, 2021. doi: 10.4239/wjd.v12.i6.706

Full Size Figure Download Figure

Figure 2 Mechanisms underlying bone fragility in type 2 diabetes mellitus. AGE: Advanced glycated end product; BMSi: Bone material strength index; CTX: C-terminal cross-linked telopeptide; GLP-1: Glucagon-like peptide-1; MSC: Mesenchymal stem cells; P1NP: Procollagen type 1 N-terminal propeptide; PTH: Parathyroid hormone; ROS: Reactive oxygen species; TRAP: Tartrate-resistant acid phosphatase.

Citation: Palui R, Pramanik S, Mondal S, Ray S. Critical review of bone health, fracture risk and management of bone fragility in diabetes mellitus. World J Diabetes 2021; 12(6): 706-729
URL: https://www.wjgnet.com/1948-9358/full/v12/i6/706.htm
DOI: https://dx.doi.org/10.4239/wjd.v12.i6.706